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Abstract 
Cohesins were first identified based on their role in chromosome segregation.  The 
products of chromosome replication must be identified from S phase until anaphase onset in 
mitosis to ensure high fidelity chromosome segregation.  Cohesin complexes tether together 
sister chromatids to maintain identity over time.  More recently, cohesins were found to play 
numerous roles in transcription regulation and other forms of DNA metabolism, including the 
firing of clustered DNA replication forks, insulator function, and replication fork restart.  Genetic 
mapping that revealed cohesin mutations are responsible for severe developmental defects 
spurred intense research regarding which role of cohesins was crucial to proper development.  
Cohesinopathies are a group of developmental disorders caused by disruption in cohesin 
function.  Cornelia de Lange Syndrome (CdLS) and Roberts Syndrome (RBS) are two examples 
of cohesinopathies that exhibit a similar suite of phenotypes but are thought to arise through very 
different cellular mechanisms.  This review investigates the similarities and differences between 
these two disorders to formulate a hypothesis unifying the relationship of these disorders as a 
possible continuum of manifestations caused by the same underlying mechanism.  
 
I.  Introduction 
 Developmental maladies are defined by clinician observations.  Such clinically-defined 
disorders are often based on just a few affected individuals, and they are made by physicians 
greatly separated both geographically and temporally.  For syndromes exhibiting similar or 
overlapping manifestations, efforts meant to differentiate them complicated studies meant to help 
define them.  Of particular interest were clinical diagnoses of numerous syndromes associated 
with mental and physical growth deficiencies and limb malformations that were later collectively 
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called cohesinopathies.  These developmental disorders are caused by the disruption in the 
normal function of a protein complex called cohesin.  The following investigation is focused on 
two cohesinopathies, Roberts Syndrome (RBS) and Cornelia de Lange Syndrome (CdLS).  First, 
both disorders are described clinically. This is followed by a review of their cellular phenotypes, 
genotoxicities, and genotypes.  Next, cohesin structure and function are presented, followed by a 
discussion that explores which cohesin functions may be impaired in RBS and CdLS.  Lastly, a 
hypothesis on the interrelationship of these disorders is proposed. 
 
II.  Clinical Manifestations in Patients 
II.A.  Roberts Syndrome 
 RBS is a rare disorder, affecting approximately 150 individuals.  As listed in Table 1, 
alternate names for the disorder include Appelt-Gerken-Lenz Syndrome, Hypomelia-
Hypoichosis-Facial Hemangioma Syndrome, Pseudothalidomide Syndrome, SC Phocomelia 
Syndrome, and Tetraphocomelia-Cleft Palate Syndrome (Gen. Home Ref. 2015).  The range and 
severity of RBS manifestations is now well documented (Vega 2005, 2010; Shule 2005).  
Affected individuals have pre- and post-natal growth retardation, reduced mental capacity, and 
physical malformations primarily of the skull, face, and limbs (Table 2).  These malformations 
include bilateral symmetric limb reduction which is worse for arms than legs, cleft lip and palate, 
microcephaly, beak nose, micrognathia, and unusually wide-set eyes (hypertelorism) with 
protruding eyeballs (exophthalmos) and corneal clouding.  The effects range widely in severity; 
however, the extent of facial malformations correlate with the extent of limb defects.  Severely 
affected individuals have high mortality rate shortly before or after birth, while individuals 
mildly affected can live longer.  
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Until recently, SC Phocomelia Syndrome was considered a disorder separate from RBS. 
In part, distinguishing between these disorders was based on the relatively mild phenotypes 
manifested in SC Phocomelia compared to those observed in RBS.  In contrast, the range of 
phenotypes were nearly indistinguishable.  An R:S rating scale for clinical severity was 
developed in an attempt to help clinicians distinguish between these two difficult-to-discern 
disorders (reviewed by Schüle 2005).  To improve the consistency of diagnoses between 
clinicians, the rating system was later modified to consider six criteria—1)survival, 2)growth 
retardation, 3)phocomelia of the arms, 4)phocomelia of the legs, 5)palatal abnormalities, and 
6)craniofacial abnormalities (reviewed by Schüle 2005).  Ultimately, the R:S system became 
defunct when SC Phocomelia Syndrome and RBS were identified as the same disorder through 
genetic mapping studies (reviewed by Schüle 2005).  The weight of evidence included that: 1) 
severely and mildly affected persons occurred in the same sibship, 2) both RBS and SC 
Phocomelia Syndrome display Heterochromatin Repulsion, which is the puffing or repulsion of 
the constitutive heterochromatin, 3) somatic cell complementation studies which showed cells 
positive for Heterochromatin Repulsion from patients with RBS and SC Phocomelia Syndrome 
both failed to complement each other, 4) cells from both syndromes exhibit mitotic cell 
premature centromere separation, and 5) mutations in the gene ESCO2 (see below) on 
chromosome 8 accounted for all the affected individuals studied.  Thus, RBS and SC Phocomelia 
Syndrome arise from mutations within the same gene that results in a broad range in severity of 
effects.  Understanding the mechanism through which identical mutations can give rise to a wide 
range in severity of effects is likely to provide important new insights regarding development 
regulation through genetics and environmental cues. 
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II.B.  Cornelia de Lange Syndrome 
 CdLS frequency of occurrence is 1:10,000 (reviewed by Krantz 2004).  The disorder is 
also known as the Brachmann-De Lange Syndrome (Table 1).  Like RBS, people with CdLS 
have growth retardation, reduced mental capacity, limb abnormalities, and distinctive 
craniofacial malformations.  Some CdLS craniofacial abnormalities are different from those in 
RBS. For instance, CdLS patients have ptosis, a beak-like nose, and no midfacial haemangioma.  
Moreover, CdLS appears to affect more systems during development than RBS: heart defects, 
impaired vision, gastrointestinal dysfunction, excessive hairiness in both sexes, hirsutism in 
women, and underdeveloped genitalia all appear pronounced in CdLS (Krantz 2004).  Reduced 
body fat, hearing loss, autism, and self-inflicting injuries also frequently occur (Kawauchi 2009).  
Intriguingly, only upper limb defects are reported in CdLS individuals while both upper and 
lower limbs are affected in RBS (Table 2) (Krantz 2004).  The significance of these distinctions 
is unknown, but could be simply an example of the range of phenotypes or penetrance caused by 
gene mutation.  For instance, it is possible that lower limb malformations are very slight in 
comparison with those of the upper arms and underreported. Another possibility is that 
individuals included in CdLS studies were only mildly affected, such that lower limb 
malformations were absent. The differences observed between CdLS- and RBS- affected 
individuals also may be due to the broad range in severity of effects. Alternatively, the 
cohesinopathies may have different underlying mechanisms, which will be discussed further. 
 
III.  Cellular Phenotypes Differentiate RBS from CdLS 
III.A.  RBS Cellular Morphology 
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The cellular phenotypes of RBS and CdLS are different.  RBS cells often contain 
micronuclei, exhibit increased frequency of aneuploidy, and contain nuclei that adopt an unusual 
morphology (Tomkins 1984).  RBS cells also display Heterochromatin Repulsion in mitotic 
spreads, which is the puffing or repulsion of the constitutive heterochromatin (Van Den Berg 
1993).  Schüle (2005) claims that Heterochromatin Repulsion is exclusively pathognomonic for 
RBS [and SC Phocomelia] and, therefore, it can be used as a diagnostic tool to differentiate RBS 
from other diseases causing phocomelia and pre-and post-natal delayed development.   
 
III.B.  RBS Genotoxic Sensitivities 
Micronuclei (like those observed in RBS cells) can form from acentric DNA fragments, 
or simply from failed mitosis in which lagging chromosomes never get to the pole to form their 
own nucleus.  These fragments often are the result of double strand DNA breaks or cellular DNA 
damage.  Cells from RBS and CdLS exposed to different agents that affect DNA  provide 
evidence supporting mitotic dysfunction, but also suggest that RBS and CdLS arise through 
different mechanisms. Such in vitro studies are critical to predict whether patients might exhibit 
different sensitivities to genotoxic agents. 
Exposure of Epstein-Barr virus (EBV)-immortalized lymphoblastoid cell lines derived 
from two persons with RBS to gamma radiation, known to cause strand breakage, increased 
micronucleation in the treated cells (Van Den Berg 1993).  Similarly, exposure of these RBS 
cells to mytomycin C, which causes DNA adducts and crosslinking by alkylation, increased 
micronucleation.  RBS cells were four times more sensitive to gamma radiation and five times 
more sensitive to mitomycin C than control cells.  The exhibited genotoxic hypersensitive 
response of RBS cells support defects in DNA repair. 
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III.C.  CdLS Cellular Morphology  
In contrast with the RBS cellular phenotype, most studies find that cells from individuals 
with CdLS typically undergo normal mitosis, and do not have exhibit either premature chromatid 
separation or Heterochromatin Repulsion (reviewed by Skibbens 2013).  Fluorescent in situ 
hybridization (FISH) revealed that cells altered to mimic CdLS exhibit altered chromosome 
architecture (Nolen 2013). For instance, chromosome architecture in lymphoblastoid cells 
derived from severe CdLS patients exhibit increased nuclear size. The investigators eliminated 
abnormal cell cycle as the cause of the increased size by demonstrating a normal cell cycle 
distribution using fluorescence-activated cell sorting analysis (FACS). These findings suggest 
that the increased nuclear size is due to chromatin decompaction—large scale unfolding of 
higher-order chromatin structure (Nolen 2013). Testing of different regions of chromatin using 
FISH indicated that the extent of decompaction is proportional to gene density (and highest 
density of CTCF, which is a regulator of transcription and chromatin architecture) and cohesin 
binding sites. In addition, cells derived from individuals with more severe phenotype have 
greater visible chromatin decompaction (Nolen 2013).  Thus, the clinical phenotypes of CdLS 
individuals may be caused by dysfunction in the regulation of gene expression. 
 
III.D.  CdLS Genotoxic Sensitivities 
Like the hypersensitive response of RBS cells, cells derived from CdLS individuals 
exhibit increased sensitivity to mitomycin C, based on the endpoints of increased cell death, 
decreased proliferation, and increased chromosomal aberrations (Vrouwe 2007).  However, 
CdLS cells were exposed to a different amount of mitomycin C than that used in the RBS study, 
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making direct comparison difficult (Vrouwe 2007).  Exposure to x-rays and gamma radiation are 
two ways of causing DNA breakage.  X-ray irradiation of CdLS cells increased chromosomal 
aberrations, but only when the exposure occurred during G2-phase of the cell cycle.  In contrast, 
RBS cells exposed to gamma radiation exhibited increasing chromosomal aberrations in 
exposure during any part of the cell cycle. The investigators suggest that the mutated CdLS cell 
sensitivity occurs when double strand DNA breakage requires establishment of sister chromatid 
cohesion for recombinational repair (Vrouwe 2007). Unfortunately, it is difficult to directly 
compare effects obtained by X-rays to those obtained by gamma radiation.   
 
III.E.  Discussion of RBS and CdLS Cellular Phenotypes  
The cellular phenotypes of these two cohesinopathies are notably different.  RBS cells 
exhibit Heterochromatin Repulsion and the results of mitotic errors. Neither occur (or are 
prominent) in CdLS cells.  On the other hand, CdLS cells have altered chromosome architecture, 
exhiniting increased nuclear size due to chromatin decompaction.  Thus far, as to genotoxic 
sensitivities, both the RBS cell and CdLS cells revealed increased sensitivities to genotoxic 
agents. However, the inability to make direct comparisons between cell-types genotoxic 
sensitivities preclude determining whether the two cohesinopathies arise through different 
mechanisms. A future study needs to expose RBS and CdLS cells concurrently to the same 
agents and at the same quantities to better compare the responses by the different cell mutations.   
 
IV.  Genetic Basis of RBS and CdLS 
IV.A.  RBS Genotype- Identified Mutated Gene  
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 To delve into the genetic basis of RBS, a genome-wide search using homozygosity 
mapping was used to locate a potentially affected locus on chromosome 8 (Vega 2005).  Using a 
candidate gene approach, the transcript LOC157570 identified eight different mutations of the 
gene ESCO2 in the 18 tested individuals from different families with RBS.  One was a missense 
mutation, another was a nonsense mutation, and six were frameshift mutations.  A later study of 
49 cases with RBS identified 26 different mutations in ESCO2 (Vega 2010).  Most of these 
mutations introduce a premature stop codon in the ESCO2 transcript by splicing, frameshift, and 
nonsense mutations, but all the ESCO2 mutations result in a missing or nonfunctional protein, 
rendering ESCO2 null (Schüle 2005). ESCO2 gene mutations are autosomal recessive.   
Genotype-phenotype analysis using Fisher exact test and McNemar test indicate no 
correlation between the severity of clinical findings and the type of ESCO2 mutation (Vega 
2010).  Another study of five families affected with RBS also indicates that genotype does not 
predict phenotype: neither the type of mutation or location in the mutated ESCO2 gene correlated 
with phenotype (Schüle 2005).  Although no correlation has been established between genotype 
and phenotype, the timing in ESCO2 expression during development correlated with the 
malformations observed in the brain, face, limb, kidney, and gonads using in situ hybridization 
on human embryos (Vega 2010).  Regardless of the specific mutation, the gene ESCO2 is 
mutated in 100% of the RBS cases (Vega 2005).  As reviewed by Schüle (2005), RBC cellular 
characteristics are not found in heterozygous cells, and they are complemented by the Chinese 
hamster genome in somatic-cell hybrids. 
ESCO2 is the abbreviated name for Establishment of Sister Chromatid Cohesion 1 
homolog 2.  The gene codes for a protein with a putative N-acetyltransferase role.  ESCO2 is 
also called EFO2 (Establishment Factor Ortholog 2).  Characterization of the ESCO2 gene, using 
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5’ and 3’ RACE and RT-PCR, found a cDNA of 3,348 nucleotides with an open reading frame 
of 1,806 nucleotides (Vega 2005).  The coding sequence consists of 11 exons spanning 30.3 kb, a 
start codon in exon 2, and a stop codon in exon 11.  The gene’s synthesized polypeptide, ESCO2 
protein, consists of 601 amino acids with a molecular weight of 68.3 kDa (Vega 2005).  
 
IV.B.  Evolutionary Conservation of ESCO2 and RBS Models 
Vertebrate ESCO2 orthologs exhibit >92%, 77%, 57%, and 41% similarity to the 
primate, rodent, chicken, and fish, respectively (Vega 2005).  The C-terminal portion of ESCO2 
is a human homolog of Saccharomyces cerevisiae Eco1p/Ctf7p (Skibbens 1999; Toth 1999).  
Schizosaccharomyces pombre Eso1p and Drosophila melanogaster Deco are also homologs 
(reviewed by Vega 2005).  Sequence similarity in different species suggests similar function(s) 
of vital importance, and enables creation of models with which to study RBS and other 
cohesinopathies.  Much of the research on RBS uses human mutant cell lines, mice, zebrafish, 
and medaka, although other models are employed. 
 
IV.C.  CdLS Genotype- Identified Mutated Gene(s) 
Through genome-wide linkage exclusion analysis in 12 families with CdLS and 
corroborative evidence of another diagnosed CdLS individual, the gene NIPBL was identified on 
chromosome 5 (Krantz 2004).  Missense mutations and frameshift mutations caused by deletions 
and insertions were spread throughout the NIPBL gene; and all the mutations are expected to 
result in a truncated or untranslated protein (Krantz 2004).  Expression patterns by northern blot 
on human adult and fetal tissues, and in situ analyses of mice embryos at days 9.5 and 10.5 of 
gestation, show that NIPBL protein is widely expressed in fetal and adult tissues (Krantz 2004).  
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Subsequent studies tend to utilize human embryonic tissue sections to avoid differences between 
mouse and human orthologs.  In situ hybridization locate NIPBL expression in human embryonic 
tissue in limbs, craniofacial regions, spinal column, and notochord.  This expression pattern is 
largely consistent with the CdLS phenotype, although a causative correlation remains to be 
determined (Tonkin 2004).   
Mutations in NIPBL are responsible for the majority of CdLS cases.  In fact, more than 
50% of gene expression and genome-wide cohesin binding patterns in cells from CdLS probands 
are due to NIPBL mutations (Liu 2009).  In addition, 80% of the mutations in the most severe 
cases of individuals having CdLS involve NIPBL (reviewed by Nolen 2013).  NIPBL stands for 
Nipped-B-like from the Nipped-B homolog in Drosophila (Tonkin 2004). However, mutations in 
two other genes on separate chromosomes also cause CdLS.  Mutations in SMC1A cause 5% of 
CdLS cases.  SMC1A is the abbreviated name for Structural Maintenance of Chromosome 1A.  
SMC1A is located on the X chromosome and is inherited as X-linked dominant.  The SMC1A 
protein is a core subunit in the cohesin complex.  A SMC3 mutation causing CdLS is very rare.  
SMC3 is the abbreviated name for Structural Maintenance of Chromosome 3.  The gene is 
located on chromosome 10 and is inherited as an autosomal dominant.  The SMC3 protein is 
another core subunit in the cohesin complex.  Mutations in NIPBL, SMC1A, and SMC3 only 
account for 65% of CdLS cases, leaving 35% of the cases currently with no known origin.  Thus, 
CdLS is more complicated than the 100% mutation incidence in ESCO2 causing RBS.  Due to 
the greater frequency in which NIPBL mutations cause CdLS and the extent of severities, the 
remainder of this review will focus on NIPBL when discussing CdLS. 
NIPBL encodes for the protein delangin, which controls the deposition of cohesin 
complex onto the DNA that makes up sister chromatids (Tonkin 2004).  Delangin belongs to a 
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family of chromosomal adherins having broad roles in sister chromatid cohesion, chromosome 
condensation, and DNA repair (Krantz 2004).  The findings of mutations in a single allele of 
NIPBL in cases with CdLS supports inheritance being an autosomal dominant (Krantz 2004).  A 
mouse model carrying one null allele of NIPBL also supports haploinsufficiency being the 
genetic mechanism of CdLS (Kawauchi 2009).  
 
IV.D.  Evolutionary Conservation of NIPBL and CdLS Models 
  As with ESCO2, NIPBL is evolutionary conserved across different species and suggests 
it has a significant role in development.  The NIPBL gene product shows homology with the 
mouse (>92%), rat (>88%), zebrafish (63%), and fruit fly NIPPED-B gene (37%) (Krantz 2004; 
Tonkin 2004).  BLAST reveals substantial homology between NIPBL and Scc2 in budding yeast 
S. cerevisiae (Krantz 2004), Nipped-B in fruit fly Drosophila melanogaster, XM_320088 in 
malaria mosquito Anapheles gambiae, PQN-85 in worm Caenorhabditis elegans, CBG0727 in 
worm C. briggae, NM_121558 in plant Arabidopsis thaliana, and NM_186173 in plant Oryza 
sativa (Tonkin 2004).  In each case, homology resides mostly in a segment of ~1,500 amino 
acids in the C-terminal half of the protein (Tonkin 2004).   
Among the models used to investigate CdLS are pectoral fin buds of Nipbl-deficient 
zebrafish larvae and NIPBL haploinsufficient mice in their entirety or limb buds. To create the 
mouse model, two mouse embryonic stem cell lines have gene-trap insertions placed in NIPBL 
(Kawauchi 2009).  The insertion creates premature termination of transcription and translation of 
the gene protein, since truncated message lacks all but the first exon.  After injecting the 
insertion into C57BL/6 blastocysts, male chimeras were subsequently bred against both inbred 
(C57BL/6) and outbred (CD-1) mice.  The frequency by which progeny created from inbreeding 
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being heterozygous (NIPBL+/-) was 5.5%.  This frequency is very low since Mendelian 
inheritance dictates a frequency of 50% heterozygous.  The chimeras outbred against CD-1 
females yielded a 19% frequency with the mutant allele.  Again, the frequency was lower than 
expected.  Further outcrosses with CD-1 females produced similar ratios, suggesting that 75-80% 
of NIPBL+/- mice die prior to genotyping (performed at 4 weeks of age).  To test for the 
occurrence of lethality in utero, litters were examined for the appearance of the mutant allele just 
prior to birth.  A frequency of 41%, versus the expected 50%, confirmed that most heterozygous 
embryos die at or after birth.  It is worth noting that 41% heterozygous frequency is still below 
the predicted value, suggesting that other parameters could be causing the lower frequency and 
confounding collected data. 
The above mouse model replicates many of the pathological features of CdLS: overall 
smaller size, heart defects, delayed bone maturation, craniofacial changes, neurological 
abnormalities, hearing deficits, decreased body fat, and high mortality soon after birth 
(Kawauchi 2009).  In addition, the model shows the same wide range in severity of the effects.  
However, this mouse model may be of limited value to investigate the mechanism underlying the 
disorder in humans.  The shortened limbs, reduced number of digit, or loss of other bony 
elements which is observed in 30-50% of individuals with CdLS, are not present in this mouse 
model.  The model exhibits only atrial septal defects, while CdLS individuals have atrial and 
ventricular septal defects.  Another difference is the corneal opacities observed in the model that 
are atypical for CdLS.  The data using NIPBL+/- mice support autosomal dominant inheritance, 
but the significant differences raise questions regarding the validity of the data collected beyond 
what is confirmed through other model systems.  
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Another model system is pectoral fin buds of Nipbl-deficient zebrafish larvae.  
Transcriptome analysis of NIPBL haploinsufficient mouse limb buds show many changes in gene 
expression similar to the zebrafish pectoral fin bud (Muto 2014).  Both the mutant pectoral fin 
buds and mouse limb buds show significant decrease in size (Muto 2014).  For instance, at 72 
hours post fertilization, the zebrafish larvae pectoral fin had a 40% decrease in size.  Evidence 
separate from an overall developmental delay is based on partial rescue by injection of 
exogenous Nipbl mRNA. In addition, decreased limb bud growth occurs in the absence of cell 
death, suggesting a cumulative effect of slower rates of cell division as the cause of the reduced 
size (Muto 2014).   
While the data may mirror what occurs in CdLS, the zebrafish pectoral fin may not be a 
good model.  These investigators identify the zebrafish pectoral fin as a homolog of the 
mammalian forelimb; however, this fin is more analogous to a human hand or wrist.  Also, the 
fin bones develop by intramembranous ossification in contrast to human long bones developing 
by endochondral ossification (personal communication Dr. M. Katherine Iovine 2/24/2015).  
Although not ideal, these models continue to provide useful information which can validated by 
human cells carrying CdLS mutations.  
 
V.  Mechanisms Posited to Produce Developmental Defects 
V.A.  Cohesin Structure and Function in Sister Chromatid Cohesion 
Cohesin is a protein complex consisting of four subunits.  The protein complex is 
evolutionary conserved, suggesting vital functional significance, and is documented for many 
species including Saccharomyces cerevisiae, Schizosaccharomyces pombre, Drosophila 
melanogaster, Xenopus laevis, and Homo sapiens.  In S. cerevisiae, the subunits are called Smc1, 
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Smc3, Mcd1/Scc1, and Scc3/Irr1.  Smc1 and Smc3 are the structural maintenance of 
chromosome units.  They are rod-shaped cohesin subunits.  Each SMC subunit has ATPase 
activity in the nucleotide-binding domain (NBD) at one end, and a dimerization domain on the 
other end.  The latter domain creates the V-shaped hinge to produce the Smc1-Smc3 
heterodimer.  Scc1 bridges the ATPase heads of the SMC subunits to form a ring-shaped 
structure, and Scc1 recruits Scc3.  The human homologs for Smc1, Smc3, Scc1, and Scc3 are 
SMC1, SMC3, RAD21, and STAG, respectively (Table 3).  Humans also contain the protein 
SORORIN, which is required to maintain cohesion, although lower species do not possess 
SORORIN. 
Additional proteins associate with the cohesin complex, while the remaining cohesion 
factors play a non-structural role.  For instance, the loading factors Scc2 and Scc4 in budding 
yeast (NIPBL and MAU2, respectively in humans) are needed during G1 phase of the cell cycle 
for the loading of cohesin onto DNA.  Eco1 in yeast (ESCO1 and ESCO2 in humans) functions 
in the establishment of cohesion between sister chromatids during S phase.  Pds5 is necessary to 
maintain cohesion.  It binds cohesins, balancing cohesin establishment with cohesin dissociation.  
Rad61 in budding yeast (WAPL in humans) functions in cohesin dissociation.  Hos1 (HDAC8 in 
humans) deacetylates the Smc3 subunit and recycles cohesin (Borges 2010).  Each of these non-
structural, cohesin-associated proteins, therefore, have multiple roles in chromosome structure, 
cell division, repair of DNA damage, and gene transcription.   
 Mapping the gene mutations through which RBS and CdLS arise provided important 
insights regarding the mechanism involved in these developmental maladies.  For instance, 
ESCO2, NIPBL, RAD21, SMC1A, SMC3 and HDAC8 all function in a singular pathway to tether 
together DNA molecules (Table 3).  The complicating issue as to why it is difficult to assign 
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mechanism to disease is that this tethering participates in numerous distinct activities.  For 
instance, SMC1, SMC3 and RAD21 form a protein complex termed cohesin.  This complex is 
implicated in several functions: chromosome segregation, DNA replication, DNA repair, and 
regulating gene expression both in proliferating and post-mitotic cells.  Cohesins were first 
identified for their role in sister chromatid pairing.  Cohesins tether together the products of 
chromosome replication, identifying them as sisters until the onset of anaphase.  The cohesin 
one-ring model suggests a mechanism through which the cohesin ring structure acts to physically 
entrap paired sister DNAs and hold them together during metaphase of mitosis and meiosis.  
Breakage in the cohesin ring can cause early separation of sister chromatids (Tόth 1999).  
Cohesin mutations result in aneuploidy—a common attribute of cancer cells.  Cohesins also can 
tether together DNA elements along the same chromosome.  In this way, cohesins can generate 
large DNA loops that allow for the close positioning of promoters and enhancers that is required 
for transcription of many genes.  
Cohesinopathies develop from mutations affecting cohesin structure or associated 
proteins responsible for the establishment, loading, or maintenance/ removal of cohesin.  Table 3 
lists key cohesin subunits and cohesin regulators, along with their functions in several species. 
The following sections offer a discussion on cohesin mechanisms implicated in RBS and CdLS 
from which I formulate a hypothesis as to the interrelationship of these disorders and possible 
unifying underlying mechanism. 
 
V.B.  Impairment of Establishment of Sister Chromatid Cohesin by RBS  
Establishment of cohesion is a process in which chromatin-associated cohesin becomes 
cohesion-“able” during S phase. It is an essential step since sister chromatid cohesion will not 
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occur simply in the presence of functional cohesin subunit loading proteins and DNA replication 
(reviewed by Vega 2005).  The discovery of Eco1/Ctf7 in yeast, and subsequent characterization 
of the human homolog ESCO1 and ESCO2, resulted in the first model of establishment activities 
as cohesin activation. Eco1 function is essential only during S phase, when the protein acetylates 
lysine residues in the Smc3 subunit of cohesin.  Eco1 mutants exhibit precocious sister 
separation.  This cohesion defect is rescued by elevated levels of DNA replication factors such as 
PCNA.  Eco1 also associates with DNA replication factors (including PCNA).  Eco1 acetylates 
only cohesins that are chromatin-bound.  Cohesin most likely undergoes a conformational 
change due to the acetylation before it can physically hold the sister chromatids together.  Cells 
with Eco1 mutation arrested prior to the beginning of anaphase show separated sister chromatids 
(Skibbens 1999).  The Eco1 links the establishment of sister chromatid adhesion to the DNA 
replication machinery (Skibbens 1999). 
ESCO2 mutations create the observed RBS cellular phenotype: premature separation of 
centromeres, lagging chromosomes, aneuploidy, and micronuclei due to mis-segregation of 
chromosomes, decreased cell proliferation due to mitotic arrest or delay, and sensitivity to DNA-
damaging agents (Vega 2005).  Similar phenotypes were observed in zebrafish– for instance, 
esco2 knockdown results in an increase in both TUNEL staining which is used to detect DNA 
fragmentation resulting from apoptotic signaling cascades, and Caspase activation which is a 
family of cysteine protease enzymes that are the executioners of apoptosis (Mönnich 2011).   
Thus, the consensus of investigations with human mutant cell lines, mice, zebrafish, and medaka 
is that the multi-system wide-range in severity of individuals with RBS may be due to the 
increased apoptosis and fewer progenitor cells due to the errors generated in mitosis caused by 
ESCO2 mutations.  
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The chromosome region(s) affected by the mutation varies with the species.  Yeast Eco1 
mutants affect cohesion both in the centromeres and chromosome arms, while fly Deco mutants 
disrupt cohesion only at the centromeres.  Human ESCO2 mutants disrupt cohesion specifically 
at heterochromatic C-banding regions around centromeres and the distal portion of the long arm 
of the Y chromosome (reviewed by Vega 2005).  Differential regulation is proposed of arm 
versus centromere cohesion in humans since most cohesin in already removed from chromosome 
arms prior to the removal of cohesin at centromeres (Giménez-Abián 2004).  Differential 
regulation may mean that another influence is behind the range of effects seen in RBS patients; 
the ESCO2 protein may have more than one function, or the singular function may initiate a 
cascade of overlapping effects. 
 
V.C.  Transcriptional Basis for CdLS Impairment? 
Cohesin loading is necessary for the association of the cohesin complex with 
chromosomes during S-phase. The genes Scc2 and Scc4 are responsible for cohesin loading in 
budding yeast.  NIPBL and MAU2 are the human homologs of Scc2 and Scc4, respectively. The 
homology suggests that NIPBL and MAU2 perform analogous roles in cohesin loading, however, 
CdLS cells do not show HR nor exhibit elevated levels of precocious sister chromatid separation 
exhibited by most cohesin mutations.  Moreover, cultured NIPBL+/- mouse embryo fibroblasts, 
NIPBL+/- embryonic stem cells, or adult B-lymphocytes failed to produce aneuploidy or cohesion 
defects (Kawauchi 2009). These results suggest that the multi-system disorders of CdLS with a 
mutation in NIPBL is caused by a mechanism distinct from that of chromosome mis-segregation 
(cohesion defects).  But how can mutations in Scc2, which loads cohesins, not have a segregation 
defect?  One possibility is that, in the heterozygous state, sufficient Scc2 protein is generated to 
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function in cohesin loading, but insufficient quantity necessary to prevent CdLS via the protein’s 
use in a separate mechanism.  
In the absence of cohesin defects that might lead to progenitor cell death, numerous 
studies instead point to alterations in transcription as the basis of CdLS.  In general, initiation of 
transcription is a major control point in gene expression.  A particular cell state is created or 
maintained by gene expression programs, and these are controlled by transcription factors.  The 
transcription factors bind to control elements called enhancers.  The location of an enhancer may 
be far from where it binds to the core promoter elements.  The enhancer-bound transcription 
factors in vitro bind coactivators, which subsequently bind the transcription initiation apparatus 
during active transcription.  For this to occur, the physical bending of DNA into a loop 
excludes/displaces the intervening DNA such that distal DNA elements come into close 
proximity. Thus, DNA loops most likely form during active transcription by selective gene 
activation. Chromosome conformation capture studies show that some cohesin dependent 
enhancers are brought close to the promoter during active transcription (reviewed by Kagey 
2010). 
The most widely accepted model is that NIPBL may influence long-range chromosomal 
regulatory interactions which could cause collective or synergistic effects—that cohesin 
regulates development by controlling the expression of many other genes.  Supporting this 
hypothesis, analysis of the RNA in the NIPBL+/- mouse model indicated a decrease of 
approximately 30% in NIPBL transcript levels, which subsequently altered protein expression in 
several hundreds of genes (Kawauchi 2009).  Differential expression was detected in 978 genes 
of the NIPBL+/- embryonic brain itself.  The findings reflect the extreme sensitivity of 
development to small changes in NIPBL activity.  
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The reduction in hundreds of gene transcript and protein expression caused by NIPBL+/- 
is similar to the decrease causing CdLS in people.  However, since a 50% decrease was expected 
if the mutated allele of the NIPBL gene is nonfunctional, the NIPBL gene may be autoregulatory.  
An up-regulation of the wild-type copy most likely occurs to compensate for the mutant NIPBL 
copy and permits sufficient quantity of delangin to be synthesized to function in chromatid 
cohesion during cell replication. The amount of delangin may be insufficient, however, for 
interphase functions related to gene regulation during development, and this would account for 
the phenotype observed in CdLS patients.  
All 16 mutant cell lines from CdLS individuals have a unique profile of dysregulated 
gene expression which could prove useful for diagnosis of the disorder (Liu 2009).  Specifically, 
NFATC2, PAPSS2, and ZNF608 were identified as biomarkers for CdLS.  These genes also 
represent affected pathways that may contribute to CdLS phenotypes. NFATC2, for example, is 
involved in multiple signaling pathways during development of muscle, cartilage, and axons.   
NFATC2 dysregulation was subsequently validated in a larger human study (Liu 2009).  The 
extent that NFATC2, PAPSS2, and ZNF608 dysregulation correlate with CdLS phenotype 
severity, however, remains undefined. 
Numerous lines of evidence support the models that NIPBL regulates transcription and 
that transcriptional dysregulation results in CdLS phenotypes.  Cebpb and EBF1, which encode 
transcriptional factors key to the differentiation of adipocytes, are down-regulated in NIPBL+/- 
mouse embryo fibroblasts (Kawauchi 2009).  This regulation may explain the decreased body fat 
observed in the mouse model and CdLS individuals.  Knockdown of NIPBL expression in 
zebrafish fin bud causes subsequent dysregulation in the expression of important early limb 
development genes, including fgfs, shha, and hand2 (Muto 2014).  Much of this work was 
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duplicated in mouse embryonic limb buds, but not every aspect was tested in both models.  For 
example, reduced zone of polarizing activity (ZPA) expression is shown in NIPBL+/- mouse limb 
buds, but there is no data for the pectoral fin.  Figure 2 summarizes the cascade of effects in 
mouse limb bud development investigated by Muto et al (2014).  Thus, a NIPBL mutation could 
explain the limb defects observed in people with CdLS. In addition, NIPBL haploinsufficiency in 
mice is detrimental to the DNA looping that controls the selective expression of erythrocyte beta-
globin (reviewed by Muto 2014).  These data suggest that NIPBL has more than one role in 
development since no single target, when mis-regulated, can explain everything.  
  Knockdown of NIPBL expression in both the mouse limb bud and zebrafish pectoral fin 
bud models also causes dysregulation expression of multiple hox genes, or homeotic genes, 
which control the body plan of an embryo along its anterior to posterior axis  (Muto 2014).  The 
changes in expression of hox genes in fin and limb bud correlate with its position in the genome.  
This effect may explain the range of severity of the effects observed in individuals with CdLS.   
Another series of investigations revealed that the Drosophila melanogaster NIPPED-B 
gene regulates Notch receptor signaling and the homeobox genes cut and Ultrabithorax (Ubx), 
which facilitates enhancer-promoter communication (reviewed by Krantz 2004). Mutations in fly 
cut causes leg and wing abnormalities, and the mouse homolog Cutl2 (or Cux2) causes 
anomalies in the branchial arch and limb bud (reviewed by Tonkin 2014).  Ubx suppresses limb 
formation in the fly abdomen by repressing the gene Distalless (Dll) which is essential for distal 
limb development. The Dlx family of mammalian Dll homologs are associated with limb, neural, 
and other developmental processes (reviewed by Tonkin 2014). NIPBL mutation may mistakenly 
activate DLX genes and cause the limb malformations observed in CdLS individuals (Tonkin 
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2014).  The assumption of a DLX role for vertebrate langins functioning in CdLS needs to be 
substantiated before accepting the proposed as true because other mechanisms are plausible.  
 
V.D.  Proposed Mechanisms of How Cohesin May Impact Transcription 
Data suggest that cohesin can function as a transcription factor via the location and 
number of its binding sites.  In control lymphoblastoid cells, cohesin preferentially binds to the 
starter (promoter) regions of actively expressed genes where there are an increased number of 
binding sites, as compared to non-transcribed genes.  In contrast, human CdLS cells have a 
general loss of cohesin binding sites, and a greater loss at transcription start sites. The result is an 
80% cohesin binding preference towards intergenic regions (Liu 2009).  The dysregulation in 
NIPBL mutation could result from decreased cohesin binding to starter regions, preventing gene 
expression. 
An alternative mechanism for how cohesin might impact transcription accounts for the 
observation that the majority of genes do not carry known cohesin binding sites (Liu et al 2009). 
Thus, cohesin might act like a boundary/insulator protein in non-coding DNA regions. This 
boundary model is supported by findings that NIPBL or cohesin binds CTCF.  CTCF (also 
known as transcriptional repressor CTCF, 11-zinc finger protein, and CCCTC-binding factor) is 
a vertebrate insulator capable of blocking enhancers from interacting with promoters or 
preventing the spread of epigenetic signals. Thus, cohesin interactions with the transcriptional 
regulator CTCF may be critical regulators of chromatin architecture.  
Relationships between NIPBL, Mediator, and cohesin in transcription are demonstrated 
in laboratory experiments.  Mediator is a large complex composed of a core which interacts with 
the gene specific transcriptional regulators and RNA polymerase II, and a Cdk8 submodule that 
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regulates transcription positively or negatively (reviewed by Muto 2014).  The use of a small 
hairpin RNA library links NIPBL, cohesins, and transcription regulators needed for the 
maintenance of murine embryonic stem cells (Kagey 2010).  The application of Hoechst to the 
stem cells stained DNA and enabled quantifiable changes in the pixel density of Oct4, a known 
master regulator of the pluripotent state.  In addition to Oct4, most known regulators of the 
murine embryonic stem cell state were identified, including Sox2 and Nanog. Importantly, 
additional components were found which implicate them as important for the maintenance of the 
stem cell state. The additional components include many subunits of the Mediator complex, 
cohesin complex, and the cohesin loading factor NIPBL.  The results suggest that murine 
embryonic stem cell pluripotency is sensitive to changes in NIPBL, Mediator, and cohesin 
components.  
If Mediator and cohesins mirror Oct4 levels in stem cells, perhaps they also regulate the 
stem cell fate?  Indeed, a knock down of Mediator, cohesin, or NIPBL all produced the same 
effects as knocking down Oct4—a loss of embryonic stem cell state. This loss of state is defined 
by a decrease in Oct4 protein, change in cell colony morphology, decreased mRNAs specifying 
transcription factors linked to pluripotency, and increased mRNAs specifying transcription 
factors for development, although the relationship between colony morphology and pluripotency 
isn’t discussed (Kagey 2010). The results suggest a very important possibility—that Mediator, 
cohesin, and NIPBL have an inter-related and essential role in gene expression.  
To further investigate how Mediator functions, chromatin immunoprecipitation coupled 
by massively parallel DNA sequencing (ChIP-Seq) was employed.  Mediator was found to 
occupy the enhancers and the promoter regions of more than 60% of actively transcribed genes 
in murine embryonic stem cells (Kagey 2010).  Mediator is a transcriptional coactivator that 
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plays a key role in transmitting regulatory signals from gene-specific activators and repressors to 
RNA polymerase II. Cohesin and Mediator co-localize on active genes.  A population of cohesin 
is associated with the enhancer and core promoter sites occupied by Mediator in many active 
promoters.  Whether interactions between Mediator and cohesin are direct or mediated by DNA 
remains unclear – an issue that will require new studies that include DNAse treatment.  In 
addition, Mediator pulls down only a very small fraction of cohesin in this study, making 
physiological relevance of this interaction questionable. Despite these limitations, the 
combination of results suggest that when transcription activators bind Mediator, the complex 
undergoes a conformational change and then binds cohesin and NIPBL (Kagey 2010).  In this 
model, cohesin connects the enhancer to the core promoter site and RNA polymerase, while 
NIPBL associated with Mediator-cohesin complexes is the factor that loads cohesin at promoters. 
This activity occurs independently of CTCF (reviewed by Nolen 2013). A schematic of the 
interaction of Mediator, NIPBL, and cohesin in transcription is shown in Figure 1. 
Is the interaction of NIPBL and Mediator conserved?  The zebrafish pectoral fin bud and 
mouse limb bud models show that NIPBL and Mediator cooperatively regulate gene expression 
to control limb development (Muto 2014).  Deficiency in Mediator subunit Med12 in the 
zebrafish pectoral fin larvae cause morphology and gene expression changes similar to NIPBL 
deficiency, and incomplete deficiency of both NIPBL and Med12 together create a strong 
synergistic effect (Muto 2014).  These results support both NIPBL and Mediator acting together 
in a common pathway.  They regulate the expression of hox genes in developing limb and fin 
buds by modulating the interaction of promoters with remote enhancers.  This is demonstrated in 
3-D fluorescent in situ hybridization with the zebrafish hoxda cluster (Muto 2014).  The model 
that NIPBL regulation is gene specific is undermined by the lack of evidence that any genes 
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remain unaffected by NIPBL knockdown.  For instance, while the effects on fgf24 gene 
expressions upon reduced NIPBL levels is modest, these are clearly reduced – in contrast to the 
authors’ claims that there is no difference.   
Is cohesin-dependent DNA looping required only for differentiation, or does it also 
maintain the differentiation state?  The difference is an important one given that DNA loops may 
be transient or long-lived and thus persist during DNA replication and transcription.  For 
instance, DNA looping is observed between enhancers and promoters co-occupied by Mediator 
and cohesin in murine embryonic stem cells and mouse embryonic fibroblasts (Kagey 2010). 
Mediator and cohesin co-occupy different promoters in different cells, enabling cell type-specific 
DNA loops linked to the selective gene expression program of each cell (Kagey 2010). Thus, the 
specific DNA loops are associated with gene activation or suppression as a consequence of the 
different promoters that Mediator and cohesin co-occupy. Problems with the ability to retain 
looping, however, might result in the inability to maintain the state of a cell type. The 
investigators propose that loss of gene transcription control may be the primary cause of CdLS 
and other cohesinopathies that cause a diverse range of developmental defects.   
 
V.E.  NIPBL Cohesin-Independent Role in Development 
Is NIPBL’s role in transcription dysregulation anchored in cohesin function?  Just this 
past year, investigators discovered that NIPBL may also have a cohesin-independent role in 
development—functioning at promoter sites as a transcription cofactor (Zuin 2014). Using 
mitotic HeLa cells fixed with paraformaldehyde and immunostained with antibodies specific for 
NIPBL, CTCF, RAD21, and SA2/STAG2, NIPBL and CTCF were found to precede cohesin 
binding to DNA with NIPBL associating at an early stage of the mitotic exit.  Conversely, 
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cohesion appearance onto chromatin occurred during or after nuclear envelope reformation.  The 
mitotic stage was determined using the marker Lamin B-EGFP which correlates with the 
reassembly of the nuclear envelop in the HeLa cells. Based on this timing, it is proposed that 
cohesin is recruited to NIPBL-bound chromatin. However, additional studies are required to 
document that NIPBL functions in transcription separate from cohesin function, since cohesin 
binds DNA long after transcription profile is put into play. 
There is evidence that supports the model that NIPBL acts independent of cohesin during 
transcription regulation.  In HB2 cells, NIPBL localizes in somatic cells independently of cohesin 
(Zuin 2014).  This function of NIPBL initially seems like a contradiction to the previously 
mentioned co-localization of NIPBL and cohesin at enhancers and core promoter regions of 
transcriptionally active genes (which are also bound by Mediator in mouse embryonic stem cells) 
(Kagey 2010).  However, Zuin et al (2014) found the presence of two different NIPBL binding 
sites based on the use of different NIPBL antibodies in ChIP sequencing protocols on HB2 cells 
and human lymphoblastoid cells. The significance of cell type used is unclear. However, 
NIPBL#1 antibodies used by Zuin (2014) bind to highly enriched “major sites” that localize at 
promoters and do not overlap with cohesin. In contrast, NIPBL#6 antibodies used by Kagey 
(2010) and NIPBL#1 bind to low-enriched “minor sites” which overlap with cohesin binding 
sites.  Approximately 80% of NIPBL “major binding sites” localize to nucleosome-free promoter 
areas which are less than 1000 base pairs from transcription start sites, in contrast with 10% of 
cohesin and CTCF sites localizing to promoters (Zuin 2014).  Analysis of RNA sequencing 
indicate that more than 98% of the NIPBL-bound genes at major binding sites are actively 
transcribed.  Analysis of major binding profiles and heat maps on human lymphoblastoid cells 
identified five transcription factors on NIPBL sites: NFYA/NFYB, SP1, PBX3, C-FOS, and 
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IRF3 (Zuin 2014).  Unfortunately, the studies stopped short of testing whether mis-regulation of 
these genes phenocopy birth defects seen in CdLS, or whether upregulating these genes in 
NIPBL knockdowns rescues CdLS phenotypes. These genes are linked to several different cell 
functions including control of the cell cycle, cell death, gene expression, control of cellular 
growth and multiplication, and RNA post-translational modification. The continued presence of 
NIPBL and MAU2 bound to protein coding genes was found necessary to maintain the levels of 
gene expression. Investigators concluded that altered gene expression when NIPBL is depleted is 
not due to decreased cohesin binding or cohesin’s function in transcription (Zuin 2014).  
Also independent from cohesin, NIPBL haploinsufficiency downregulates the canonical 
Wnt pathway in zebrafish embryos and CdLS patients fibroblasts (Pistocchi 2013).  The 
canonical Wnt pathway is a signal transduction pathway involved in the regulation of gene 
transcription during embryonic development, controlling processes that include cell proliferation, 
cell fate or differentiation, cell migration, and body axis.  While investigating the effects of 
nipblb loss of function in the developing hindbrain in zebrafish embryos, NIPBL expression was 
found localized in the central nervous system at 24 hours post fertilization (hpf).  Injected with 
nipblb-morpholino, 50% (100/200) of the embryos were microphthalmic and microcephalic at 24 
hpf, and Western blot analysis determined Nipbl protein level reduced by 39% compared to 
controls (Pistocchi 2013).  Increased apoptosis, with no alteration in proliferation, was observed 
in the central nervous system of nipblb-knocked down embryos in the areas where nipblb is 
normally expressed.  Based on expression of AP identity markers hoxb2a, pax2a, and krox20, 
and the marker atoh1 of hindbrain dorsal progenitors and ventricle opening, central nervous 
system axis and anatomical patterning may be unaffected by nipblb- morpholino at 24 hpf.  Also 
unaffected was neuronal differentiation of the dopaminergic cell population.  However, 80% 
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(96/120) had mis-regulation of wnt1 expression, with the severity of phenotype correlating with 
the extent of hindbrain fusion.  axin2 expression, a key downstream component of the wnt 
pathway, was similarly mis-regulated (Pistocchi 2013). 
One direct target of the canonical Wnt pathway, Cyclin D1 or CCND1, was 
downregulated in NIPBL haploinsufficiency.  Fibroblasts from patients with CdLS had almost 
50% decrease in CCND1 (Pistocchi 2013).  Ccnd1 levels in nipblb- morpholino injected 
zebrafish embryos showed decreases by q-PCR, western blot analysis, and whole-mount in situ 
hybridization (WISH).  Also observed were decreases in the active form of beta-catenin in the 
CdLS fibroblast and zebrafish models.  The phenotype of the nipblb- morpholino injected 
zebrafish embryos could be rescued by chemically inducing the Wnt pathway with lithium 
chloride.  Results included restored morphology of cephalic structures, wnt1 distribution pattern 
similar to control embryos, reduction in elevated apoptosis levels, increased active form of beta-
catenin, and increased cnd1 levels. 
Therefore, the evidence suggests that NIPBL plays multiple roles in developmental 
regulation by loading cohesin onto the chromatin, indirectly alter gene expression via long range 
chromosomal interactions in conjunction with cohesin and with or without CTCF. These long 
range interactions maintain the architecture in higher-order chromatin structure, directly 
affecting genes when NIPBL binds to promoters, and impacting the canonical Wnt pathway.  It is 
presently unknown how many gene expressions are primarily due to direct NIPBL transcription, 
or how many are secondary effects caused by gene dysregulation.  
 
V.F. Impact of ESCO2 on Transcription Regulation of Genes Downstream  
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Since NIPBL regulates transcription in development, might ESCO2 also have this 
function? A microarray analysis of Esco2-depleted zebrafish embryos was used to examine the 
genes regulated downstream of Esco2 (Mönnich 2011). Instead of enrichment for transcriptional 
regulators responsible for the generation of CdLS, the RNAs differentially expressed in esco2 
morphants were enriched for RNAs associated with the cell cycle—cell proliferation and 
apoptosis—instead of any particular functional category or developmental gene mis-regulation. 
The data support high levels of cell proliferation defects and cell death created by the disruption 
of the cell cycle as the primary cause of RBS features, in contrast to the alteration of 
developmental pathways in CdLS.  Therefore, Mönnich et al (2011) conclude that RBS and 
CdLS are distinct diseases, and that they are grouped as cohesinopathies because both have 
mutations in genes in proteins responsible for sister chromatic cohesion. 
 
V.G. Cohesinopathy vs. Trancriptomopathy 
 
Identified as a single group of disorders permits speculation that all cohesinopathies have 
a common underlying mechanism.  Recently, Yuan et al (2015) proposed transcriptional 
disturbances as the common underlying mechanism unifying several developmental maladies, 
including CdLS.  Claiming that the syndromes exhibit similar or overlapping CdLS-like 
manifestations in multiple systems and broad range of severity, the investigators would prefer to 
call the collection of syndromes “transcriptomopathies,” each syndrome caused by mutations in 
different genes related to transcription; CdLS should not be called a cohesinopathy but a 
transcriptomopathy.  The eight syndromes reviewed include Wiedemann-Steiner syndrome 
(WDSTS; Hairy Elbows Syndrome), Floating-Harbor syndrome, and Rubinstein-Taybi 
syndrome, in addition to CdLS.  Roberts Syndrome was not included in the study.  The 
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justification for reviewing these eight syndromes together, according to the researchers, are the 
overlapping phenotypes.  However, when examining the table of characteristics, the 
commonality isn’t as obvious.  For example, excessive hair growth of the upper and lower arm 
around the elbow area is a prominent WDSTS clinical feature, while general excessive hairiness 
is common in CdLS in both sexes, but not in all CdLS individuals. Another reason for the review 
of these syndromes collectively are the mutations that the investigators observed. 
CdLS-like phenotypes are caused by mutations in different genes, while WDSTS is 
caused by mutation in lysine-specific methyltransferase 2A (KMT2A) on the X-chromosome.  
KMT2A is thought to be a broad regulator of gene transcription.  Whole-exon sequencing 
(WES) for two brothers diagnosed with WDSTS identified a hemizygous missense mutation in 
SMC1A (Yuan 2015).  It is unclear in the publication if the two brothers also have a KMT2A 
mutation, but SMC1A mutation is known to cause CdLS.  Since syndromes and diagnoses are 
first identified through observations made by clinicians, and due to the broad spectrum and 
varied intensity of effects for each of these syndromes, it is possible that instead of a common 
mechanism unifying WDSTS and CdLS, an alternative explanation may be that the brothers 
were incorrectly diagnosed.  Similarly, one of 32 Turkish patients diagnosed with CdLS and 
having clinical features of CdLS (and not WDSTS) had a novel heterozygous nonsense KMT2A 
mutation, detected by WES using DNA samples extracted from the peripheral blood.  In 
addition, one patient with characteristics of both CdLS and WDSTS had a mutation in SMC1A, 
while another patient with characteristics of both CdLS and WDSTS had a mutation in SMC3 
(Yuan 2015).  Thus, it is unclear as to whether mis-diagnoses is prevalent in the diagnoses of 
these syndromes, or if there is a transcriptional commonality causing them.  Also, since SMC1A 
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and SMC3 contributed to some phenotypes resembling WDSTS, perhaps the molecular 
mechanism by which WDSTS is generated involves cohesin genes and proteins.  
Yuan et al (21015) also identify a population in Saudi Arabia with CdLS-like phenotype 
that would be the first report of an autosomal recessive inheritance responsible for the disease. 
This population has a variant in TAF6 gene, coding for Transcription initiation factor TFIID 
subunit 6 which may function in activation or promoter recognition to facilitate the initiation of 
transcription by RNA polymerase II. The phenotype requires homozygous recessive mutation in 
TAF6.  But should this population be associated with CdLS?  Since RBS has autosomal recessive 
inheritance, the question is really what defines CdLS-like?  Is a group of syndromes being made 
to fit a hypothesis? 
 
VI. Final Thoughts- Discussion of Cohesinopathy Commonality 
 
RBS, CdLS, and the other cohesinopathies share some common features but appear to be 
clinically distinct.  Multiple systems are affected, albeit different in their number of systems, and 
they manifest themselves in a broad range of severity.  To target several systems plus vary the 
extent to which targets are affected suggests to me simultaneous mechanisms: one direct 
mechanism that disrupts cohesion function, and the second indirect mechanism via transcription 
that can cause developmental gene dysfunction or cell cycle disruptions.  Figure 3 describes my 
proposed interpretation of the dual mechanism in NIPBL mutation, which would occur in a 
simultaneous gradation.  As with the case of NIPBL, a mutation in this gene prevents the loading 
of cohesin onto chromatin, and regulates development by controlling the expression of multiple 
other genes.  A dual function exists for ESCO2, but the affected downstream genes are 
associated with the cell cycle.  The same studies on binding to promoters, indirectly altering gene 
expression via long range chromosomal interactions in conjunction with cohesin and with or 
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without CTCF, and maintaining the architecture in higher-order chromatin structure should be 
performed with ESCO2.  The dual functions of both NIPBL and ESCO2 in cohesion function and 
transcription suggests a unifying mechanism that can explain how all cohesinopathies develop 
while still creating the distinct characteristics of each disorder.  Assume a continuum of 
manifestations exists.  At one end is the disruption of cohesion during S phase, causing increased 
errors in mitosis leading to apoptosis and aberrant development due to fewer progenitor cells.  
The other end is transcriptional control, either of the cell cycle or the dysregulated expression of 
multiple developmental genes during G0 and G1, which also causes aberrant development.  A 
mutation in ESCO2 is more of a mitotic error causing fewer progenitor cells, and NIPBL is more 
gene transcriptional dysregulation.  The continuum has a central area with overlapping or 
common effects.  Other cohesinopathies may fall somewhere in between on this continuum and 
would depend on the genes transcribed downstream from the mutation.  Acetylation is necessary 
in both processes.  Lysine residues in the Smc3 subunit of cohesin are acetylated before cohesin 
can physically hold together sister chromatids. Acetylation also tends to open up the coiled 
chromatin to enable transcription.  It is important to note that the cohesinopathies are created by 
the loss of control in gene expression, while cancer can arise from improper chromosome 
segregation or an inability to repair DNA damage. Thus, dysfunction of cohesion causing a 
mitotic error can develop into a cohesinopathy, but it can also develop cancer if the abnormal 
cell survives and does not undergo DNA repair. 
The continuum itself can be the cell cycle and the role cohesin plays in the different parts 
of the cycle.  For example, the synthesis stage or S stage is DNA replication.  Therefore, 
mutation in ESCO2 prevents the establishment of cohesin with the result of mitotic errors due to 
failed sister chromatid cohesion.  A NIPBL mutation disrupts normal growth and preparation for 
 Sternberg  p. 33 
 
 
 
DNA synthesis by dysregulation of gene transcription.  Figure 4 shows my hypothesis of the 
links between the cell cycle phases, cohesin activities, NIPBL and ESCO2 which can unify all 
cohesinopathies but still reflect their distinct differences.   
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Table 1. 
 
Overview of Roberts Syndrome and Cornelia de Lange Syndrome 
 
 
 
Roberts Syndrome 
(RBS) 
 
 
Cornelia de Lange Syndrome 
(CdLS) 
Alternate 
Names 
Appelt-Gerken-Lenz Syndrome; 
Hypomelia-Hypotrichosis-Facial 
Hemangioma Syndrome; 
Pseudothalidomide Syndrome;  RBS;                                      
Roberts-SC Phocomelia Syndrome; SC 
Phocomelia Syndrome; 
SC Pseudothalidomide Syndrome; 
SC Syndrome; 
Tetraphocomelia-Cleft Palate Syndrome 
BDLS;  
Brachmann-De Lange Syndrome; 
CDLS; 
De Lange Syndrome 
Frequency of 
Occurrence 
~150 cases 1 in 10,000 
Inheritance Homozygous recessive Autosomal dominant: NIPBL, SMC3; 
X-link dominant: SMC1A 
Gene 
mutated 
ESCO2: in 100% of cases  NIPBL: present in >50% cases 
 SMC1A: 5% of cases  
 SMC3: rare  
35% of cases unknown cause 
Gene full 
name 
ESCO2 : “establishment of sister  
     chromatid cohesion N- 
     acetyltransferase 2” 
 NIPBL: “Nipped-B homolog 
(Drosophila).” 
 SMC1A: “structural maintenance of 
chromosome 1A” 
 SMC3: “structural maintenance of  
chromosome 3” 
Gene location Chromosome 8 at position 21.1 from 
base pair 27,774,540 to base pair 
27,812,623 
 
 
 NIPBL on chromosome 5 at position 
13.2 base pairs 36,876,758 - 
37,065,823 
 SMC1A on the X chromosome 
between positions 11.22 and 11.21 
base pairs 53,374,148 - 53,422,727  
 SMC3 on chromosome 10 at position 
25 base pairs 110,567,690 - 
110,604,633 
Defective 
protein 
ESCO2 protein: functions in the 
establishment of cohesion between sister 
chromatids. Cells respond by delaying 
cell division and can be a signal that the 
cell should undergo self-destruction.  
 Delangin, from NIPBL: controls the 
interaction between the cohesion 
complex and the DNA that makes up 
the sister chromatids.  
 SMC3 protein, from SMC3: part of a 
protein group called the cohesion 
complex that holds the sister 
chromatids together. 
 SMC1 protein, from SMC1: part of a 
protein group called the cohesion 
complex that holds the sister 
chromatids together. 
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Table 2. 
 
Major Clinical Features in Robert’s Syndrome and Cornelia de Lange Syndrome, 
and Some Reported Incidence Frequencies* 
 
ROBERT’S SYNDROME 
(RBS) 
CORNELIA DE LANGE SYNDROME 
(CdLS) 
 Growth retardation- 100% 
 Mental retardation- ~60% 
- No problems reported on behavioral 
parameters  
 Craniofacial abnormalities 
- Head 
o Microcephaly- ~95% 
o Brachycephaly- ~63% 
- Eyes 
o Exophthalmos- ~60% 
o Hypertelorism- ~85% 
o Corneal opacity- ~36% 
- Ears 
o Misshapen- ~66% 
o No hearing loss reported 
- Nose/Mouth/Chin 
o Narrowed nostrils- ~92% 
o Midfacial hemangioma- ~68% 
o Cleft lip and palate- ~55% 
o Micrognathia- ~75% 
 Limb abnormalities- 100% 
- Phocomelia 
- Bilaterally, arms affected more than legs  
- Predominantly all four appendages 
affected 
 Cardiac defects- ~26% 
 Enlarged phallus/clitoris-~25-45% 
 Cryptorchidism- ~25-45% 
 Growth retardation 
 Mental retardation 
- Aggressive behavior, autism, self-
inflicting injuries, seizures 
 Craniofacial abnormalities 
- Head 
o Microcephaly 
o Brachycephaly 
- Eyes 
o Ptosis 
o Myopia 
o No corneal opacity reported 
- Ears 
o Misshapen 
o Hearing loss 
- Nose/Mouth/Chin 
o Beak-like nose 
o No midfacial haemangioma 
o Cleft lip and palate 
o Micrognathia 
 Limb abnormalities- ~33% 
- Phocomelia  
- Bilaterally, arms affected more than legs  
- Predominantly only upper extremities 
affected 
 Cardiac defects 
 Underdeveloped male genitals 
 Cryptorchidism  
 Hypospadias 
 Small and abnormal kidneys 
 Unibrow (synophyrs) and overall 
excessive hairiness (hirsutism) 
 Gastro-esophageal dysfunction 
 Reduced body fat 
*  Both RBS and CdLS individuals have growth retardation, reduced mental capacity, distinctive 
craniofacial malformations, and limb abnormalities; however, specific clinical details that differ in 
these characteristics are highlighted in bold, along with additional irregularities. 
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Table 3. Cohesin Subunits and Regulators in Several Species         
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Figure 1. Interaction of Mediator, NIPBL, and Cohesin in Transcription 
 
 
Modified from: http://www.nature.com/nature/journal/v467/n7314/images/467406a-f1.2.jpg 
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Figure 2. Cascade of Effects in Limb Bud Development 
 
 
 
 [Data from Muto et al. (2014). Nipbl and Mediator Cooperatively Regulate Gene Expression to Control Limb 
Development. PLOS Genetics 10(9):1-22, e1004671] 
 
 
 
 
Figure 3. Proposed Interpretation of the Dual Mechanism in NIPBL Mutation 
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Figure 4. Linking Cell Cycle Phases, Cohesin Activities, and the Cohesinopathies of NIPBL 
& ESCO2 
 
 
Modified from: http://www.nature.com/nrc/journal/v14/n6/images_article/nrc3743-f2.jpg and 
http://www.bdbiosciences.com/in/wcmimages/apoptosis_analysis_cellcycle_phases_lrg.jpg 
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